Hybrid Approach to Identify Druglikeness Leading Compounds against COVID-19 3CL Protease. (arXiv:2208.06362v2 [q-bio.BM] UPDATED)

SARS-COV-2 is a positive single strand RNA based macromolecule that has
caused the death of more than 6.3 million people since June 2022. Moreover, by
disturbing global supply chains through lockdown, the virus has indirectly
caused devastating damage to the global economy. It is vital to design and
develop drugs for this virus and its various variants. In this paper, we have
used an In-Silico study framework to repurpose existing therapeutic agents to
find drug-like bioactive molecules that could cure …

arxiv bio covid covid-19 hybrid hybrid approach identify